Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 15, 2014 - Issue 4
Submit an article Journal homepage
4,478
Views
10
CrossRef citations to date
0
Altmetric
Editorial

Agomelatine: a new option for treatment of depression?

Chi-Un PaeThe Catholic University of Korea, College of Medicine, Department of Psychiatry, Seoul, South Korea+82 32 340 7067; +82 32 340 2255; [email protected];Duke University Medical Center, Department of Psychiatry and Behavioral Medicines, Durham, NC, USA
, MD PhD
Pages 443-447 | Published online: 08 Jan 2014

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Cay Laurene Goh, Jacinta Trudy Cheng, Mithu Palit, Shane Costello & David Anthony Barton. (2023) Pharmacological management of neuropsychiatric symptoms in geriatric traumatic brain injury: a scoping review. Brain Injury 37:4, pages 356-371.
Read now
Massimiliano Buoli, Silvia Grassi, Marta Serati & A. Carlo Altamura. (2017) Agomelatine for the treatment of generalized anxiety disorder. Expert Opinion on Pharmacotherapy 18:13, pages 1373-1379.
Read now

Articles from other publishers (8)

Rosa Savino, Anna Nunzia Polito, Gabriella Marsala, Antonio Ventriglio, Melanie Di Salvatore, Maria Ida De Stefano, Anna Valenzano, Luigi Marinaccio, Antonello Bellomo, Giuseppe Cibelli, Marcellino Monda, Vincenzo Monda, Antonietta Messina, Rita Polito, Marco Carotenuto & Giovanni Messina. (2023) Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders. Brain Sciences 13:5, pages 734.
Crossref
Joseph SadekJoseph Sadek. 2021. Clinician’s Guide to Psychopharmacology. Clinician’s Guide to Psychopharmacology 17 57 .
Michele Protti, Roberto Mandrioli, Camilla Marasca, Andrea Cavalli, Alessandro Serretti & Laura Mercolini. (2020) New‐generation, non‐SSRI antidepressants: Drug‐drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others. Medicinal Research Reviews 40:5, pages 1794-1832.
Crossref
Ahmed Naguy & Bibi Alamiri. (2020) Agomelatine Use in Child and Adolescent Psychiatry. American Journal of Therapeutics 27:5, pages e556-e558.
Crossref
Cecilio Álamo, Francisco López-Muñoz & Pilar García-García. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy 445 463 .
Chi-Un Pae. (2015) Why Systematic Review rather than Narrative Review?. Psychiatry Investigation 12:3, pages 417.
Crossref
Changsu HanSheng-Min WangSoo-Jung LeeTae-Youn JunChi-Un Pae. (2015) Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice. Chonnam Medical Journal 51:2, pages 66.
Crossref
Cecilio Álamo, Francisco López-Muñoz, Pilar García-García & Silvia García-Ramos. (2014) Risk-benefit analysis of antidepressant drug treatment in the elderly. Psychogeriatrics 14:4, pages 261-268.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.